Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women

scientific article published on 01 December 2007

Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1538-7836.2007.02763.X
P698PubMed publication ID18034767

P50authorPier Luigi MeroniQ38544871
Flora PeyvandiQ39183632
Pier Mannuccio MannucciQ69358288
Angela TincaniQ73304219
P2093author name stringFetiveau R
Bernardinelli L
Foco L
P433issue12
P921main subjectmyocardial infarctionQ12152
P304page(s)2421-2428
P577publication date2007-12-01
P1433published inJournal of Thrombosis and HaemostasisQ6296004
P1476titleAnti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women
P478volume5

Reverse relations

cites work (P2860)
Q38885685Anti-phospholipid Antibodies and Smoking: An Overview
Q43626449Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
Q64046338Antiphospholipid syndrome
Q37824302Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases
Q64262888Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form
Q37853050Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome
Q33393146Hughes syndrome (the antiphospholipid syndrome): a disease of our time
Q43672062IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality
Q37351603Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients
Q92369603Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
Q36932166Is preclinical autoimmunity benign?: The case of cardiovascular disease
Q37428743Management of cardiovascular disease risk in chronic inflammatory disorders
Q37810821New Insights into the Biology and Pathobiology of Beta2-Glycoprotein I
Q35895238Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Q37549027Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
Q40838962Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study
Q57821678Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
Q83114699Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world

Search more.